In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on management of melanoma, with articles on nodal management, stage 4 surgery, margins, systemic therapy, and neoadjuvant therapy, as well as vaccines in melanoma and ocular and mucosal melanoma.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations - p. 297 10. Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions) - p. 319 11. Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery? - p. 343 12. Systemic Therapy for Melanoma: What Surgeons Need to Know - p. 359 13. Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/Resectable Stage IV Melanoma - p. 375 14. Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy - p. 393 15. Vaccines in Melanoma: Past, Present, and Future - p. 411 16. Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons - p. 423 17. Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas - p. 437 18. Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment - p. 453
In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on management of melanoma, with articles on nodal management, stage 4 surgery, margins, systemic therapy, and neoadjuvant therapy, as well as vaccines in melanoma and ocular and mucosal melanoma.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations - p. 297 10. Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions) - p. 319 11. Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery? - p. 343 12. Systemic Therapy for Melanoma: What Surgeons Need to Know - p. 359 13. Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/Resectable Stage IV Melanoma - p. 375 14. Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy - p. 393 15. Vaccines in Melanoma: Past, Present, and Future - p. 411 16. Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons - p. 423 17. Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas - p. 437 18. Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment - p. 453
